Stephens Inc’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-12,711
Closed -$221K 1281
2023
Q3
$221K Sell
12,711
-2,417
-16% -$50.4K ﹤0.01% 1000
2023
Q2
$315K Sell
15,128
-5,199
-26% -$113K 0.01% 900
2023
Q1
$478K Sell
20,327
-6,937
-25% -$186K 0.01% 729
2022
Q4
$761K Sell
27,264
-2,631
-9% -$67.3K 0.02% 570
2022
Q3
$700K Buy
29,895
+285
+1% +$8.61K 0.01% 599
2022
Q2
$999K Sell
29,610
-3,485
-11% -$122K 0.02% 519
2022
Q1
$1.16M Sell
33,095
-15,605
-32% -$534K 0.02% 551
2021
Q4
$1.48M Buy
48,700
+5,596
+13% +$182K 0.02% 514
2021
Q3
$1.41M Buy
43,104
+8,225
+24% +$263K 0.02% 546
2021
Q2
$1.05M Buy
+34,879
New +$1.15M 0.02% 643

Other funds holding OGN

Stephens Inc's OGN Position: Q4 2023 in Review

Stephens Inc sold out of Organon & Co (OGN) in Q4 2023, closing a stake of 12,711 shares — an estimated $221K sold.

Stephens Inc first reported a position in OGN in Q2 2021 and held it in 10 quarters. The position peaked at $1.48M in Q4 2021. 719 funds tracked by Wall St. Rank hold OGN as of Q4 2023.

  • Stephens Inc reported no remaining Organon & Co position as of Q4 2023 after selling out during the quarter.
  • Stephens Inc sold 12,711 Organon & Co shares in Q4 2023, an estimated $221K.
  • Stephens Inc first reported a position in Organon & Co in Q2 2021 and held it in 10 quarters.
  • Stephens Inc's Organon & Co position peaked at $1.48M in Q4 2021.
  • 719 funds tracked by Wall St. Rank held Organon & Co as of Q4 2023.

Based on Stephens Inc's 13F filing for Q4 2023, filed 13 Feb 2024.